Molecular markers INHBA and SPP1 and application thereof
A technology of molecular markers and markers, applied in the direction of recombinant DNA technology, biochemical equipment and methods, DNA/RNA fragments, etc., can solve the problem of inability to better meet clinical needs, incomplete clarity of molecular markers for lymph node metastasis, etc. problem, to achieve high accuracy, high repeatability, and small sample size
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0033] Primary Screening of Example 1 Molecular Markers
[0034] First of all, establish a database of patients with gastric cancer that collects patient clinicopathological data, multi-level biological samples and follow-up data. Sexual (negative) lymph node samples.
[0035] After preliminary case screening: patients with gastric adenocarcinoma diagnosed by pathology, with detailed medical records and complete postoperative pathological data and follow-up data were included; neoadjuvant therapy was excluded; patients who underwent non-tumor resection such as laparotomy and gastrojejunostomy were excluded; Patients with other gastric malignancies and postoperative recurrence of gastric cancer were excluded; patients with simultaneous or metachronous combination of other primary malignancies were excluded.
[0036] Finally, 66 pairs of gastric primary tumor tissues and paired normal tissue samples, 50 cases of metastatic (positive) lymph node samples and 54 cases of non-metas...
Embodiment 2
[0038] Example 2 Detection of Expression Levels of Molecular Targets
[0039] Test samples: A total of 66 pairs of gastric primary tumor tissues and paired normal tissue samples, 50 cases of metastatic (positive) lymph node samples and 54 cases of non-metastatic (negative) lymph node samples collected were analyzed. All specimens were collected within half an hour of the tumor in vitro during gastric cancer resection. The tumor tissue was taken from the solid area of the tumor to avoid the necrotic area, and the normal tissue was the gastric mucosa more than 4cm away from the tumor. All were cut into 0.5cm×0.5cm ×0.5cm in size and retained; perigastric lymph nodes refer to regional lymph nodes (lymph nodes 1 and 2), and enlarged perigastric lymph nodes with hard mass and diameter > 1 cm and soft non-swelled lymph nodes with diameter 1.8 and A260 / 230 close to 2.0 met the requirements.
[0040] Detection method: Detect the expression of the nine molecular targets in Example 1 ...
Embodiment 3
[0051] Example 3 Kit
[0052] An embodiment of the early gastric cancer diagnostic kit of the present invention, which contains a primer pair for detecting the mRNA of INHBA and SPP1, wherein the base sequences of the primer pair are as shown in SEQ ID NO.7-8 and SEQ ID NO.9-10 Show.
[0053] An embodiment of the kit for predicting lymph node metastasis status of patients with gastric cancer of the present invention, which contains a pair of primers for detecting the mRNA of INHBA and SPP1, wherein the base sequences of the primer pairs are as SEQ ID NO.7-8 and SEQ ID NO. 9 to 10.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com